Skip to main content
. Author manuscript; available in PMC: 2018 Jan 18.
Published in final edited form as: Bioconjug Chem. 2016 Nov 16;28(1):23–32. doi: 10.1021/acs.bioconjchem.6b00569

Figure 3.

Figure 3

Platelet-mimicking nanovehicles (PM-NVs) for targeted cancer drug delivery. (A) Schematic of PM-NV targeting mechanisms to both circulating and primary tumor cells. (B) In vivo fluorescence imaging of PM-NV biodistribution in MDA-MB-231 tumor-bearing nude mice for (i) Cy5.5-labeled TRAIL-DOX-NVs (ii) and Cy5.5-labeled TRAIL-DOX-PM-NVs. (C) MDA-MB-231 tumor growth curves after intravenous injection of different TRAIL/DOX formulations. Error bars indicate s.d. (n = 5). Adapted with permission from reference 50. Copyright 2015, Wiley.